PBM Alliance with Walgreens seeks to lower drug costs, improve outcomes

Published Online:┬áSep 01,2016 Laurie Toich, Assistant Editor Drug costs have become a hot button issue throughout the healthcare and pharmaceutical industries, as patient outcomes and value-based care take center stage. The US Centers for Medicare and Medicaid Services has focused on both aspects of healthcare through proposed rules and payment models, among other cost-controlling actions. Executives at Prime Therapeutics, a …